Oriental Renaissance: Innovative,
educational, natural and social sciences
VOLUME 2 | ISSUE 5
ISSN 2181-1784
Scientific Journal Impact Factor
SJIF 2022: 5.947
Advanced Sciences Index Factor
ASI Factor = 1.7
605
w
www.oriens.uz
May
2022
16.
Segura
J, Campo C, Gil P, Roldán C, Vigil L, Rodicio JL et al. Development of
chronic kidney disease and cardiovascular prognosis in essential hypertensive
patients. J Am Soc Nephrol. 2004;15(6):1616
–
1622.
17.
Oshchepkova EV Dolgusheva IuA, Zhernakova IuV, Chazova IE
, Shal’nova
SA, Iarovaia EB et al. The prevalence of renal dysfunction in arterial hypertension (in
the framework of the ESSE-RF study). Sistemnye Gipertenzii = Systemic
Hypertension. 2015;12(3):9
–
24. In Russian.
18.
Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury.
Blood Purification. 2010;29(4):357
–
365. doi:10.1159/000309421
19.
Abassi Z, Sagi O, Armaly Z, Bishara B. Neutrophil gelatinase-associated
lipocalin (NGAL): a novel biomarker for acute kidney injury. Harefuah.
2011;150(2):111
–
116.
20.
Må
rtensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury
and failure: clinical applicability. Br J Anaesth. 2012;109(6):843
–
850.
doi:10.1093/bja/aes357
21.
Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in
renal disease. Clinica Chimica Acta; International Journal of Clinical Chemistry.
2006;374(1
–
2):1
–
7.
22.
Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR et al.
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney
disease. Clin J Am Soc Nephrol. 2009;4(2):337
–
344. doi:10.2215/CJN.03530708
23.
Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv
Chronic Kidney Dis. 2010;17(6):469
–
479. doi:10.1053/j.ackd.2010.09.002
24.
Satoh-Asahara N, Suganami T, Majima T, Kotani K, Kato Y, Araki R et al.
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic
kidney disease in patients with obesity and metabolic syndrome. Clin J Am Soc
Nephrol. 2011;6 (2):265
–
273. doi:10.2215/CJN.04830610
25.
Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M.
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in
subjects affected by chronic kidney disease. Kidney Blood Press Res.
2008;31(4):255
–
258. doi:10.1159/000143726
26.
Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C et al.
Transcriptional analysis of kidneys during repair from AKI reveals possible roles for
NGAL and KIM
‑
1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal
Physiol. 2010;298(6): F1472
–
F1483. doi:10.1152/ajprenal.00619.2009
Do'stlaringiz bilan baham: |